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FcgRIIB1 Inhibition of BCR-Mediated
Phosphoinositide Hydrolysis and Ca21 Mobilization
Is Integrated by CD19 Dephosphorylation
Keli L. Hippen,*²³ Anne Mette Buhl,*² al., 1994). Phosphorylation of this tyrosine is required
for negative signaling (Muta et al., 1994) and mediatesDaniele D'Ambrosio,*§ Kazuhiro Nakamura,*
binding to and activation of the Src homology domainChristoph Persin,*‖ and John C. Cambier*
2 (SH2)±containing tyrosine phosphatase SHP-1 (also*Division of Basic Sciences
known as PTP1C, HCP, and SHPTP-1) (D'Ambrosio etDepartment of Pediatrics
al., 1995). The FcgRIIB1 phosphotyrosine also mediatesNational Jewish Medical and Research
receptor binding to SHP-2 (also known as PTP1D, Syp,Center
and SHPTP-2) and SHIP, a phosphatidylinositol-3,4,5-Department of Immunology
trisphosphate (PI-3,4,5-P3) 59- phosphatase (D'Am-University of Colorado Health Sciences
brosio et al., 1996; Damen et al., 1996; Ono et al., 1996).Center
Furthermore, SHIP is tyrosine phosphorylated uponDenver, Colorado 80206
BCR±FcgRIIB1 coligation (Chacko et al., 1996). Although
the roles of SHP-2 and SHIP in inhibitory signaling are
unclear, SHP-1 expression has been shown to be essen-Summary
tial for FcgRIIB1 inhibition of BCR-induced B cell prolif-
eration (D'Ambrosio et al., 1995). Recent findings indi-The B cell receptor for immunoglobulin G, FcgRIIB1,
cate that certain other immune system receptors,is a potent transducer of signals that block antigen-
notably the killer inhibitory receptors and CTLA-4, alsoinduced B cell activation. Coligation of FcgRIIB1 with
utilize SHP-1 and/or the closely related SHP-2 phospha-B lymphocyte antigen receptors (BCR) causes prema-
tase for transduction of inhibitory signals, but interest-ture termination of phosphoinositide hydrolysis and
ingly these receptors do not bind SHIP (Burshtyn et al.,
Ca21 mobilization and inhibits proliferation. This inhibi- 1996; Marengere et al., 1996; Olcese et al., 1996; Vely
tory signal is mediated in part by phosphorylation of
et al., 1997). The logical nextstep inunderstanding these
FcgRIIB1 and recruitment of phosphatases; however, inhibitory signaling processes is elucidation of the mo-
the molecular target(s) of effectors is unknown. Here lecular site of action of the FcgRIIB1 effectors.
we report that FcgRIIB1 inhibition of BCR signaling is FcgRIIB1 has been shown to exercise its effect by
mediated in part by selective dephosphorylation of inhibiting BCR- mediated phosphoinositide hydrolysis
CD19, a BCR accessory molecule and coreceptor. and calcium mobilization (Bijsterbosch and Klaus, 1985;
CD19 dephosphorylation leads to failed CD19 associa- Wilson et al., 1987; Choquet et al., 1993), placing the
tion with phosphatidylinositol 3-kinase, and this in turn site of action of Fc receptor effector at or above inositol
leads to termination of inositol-1,4,5-trisphosphate lipid hydrolysis in the BCR signaling cascade. Some
production, intracellular Ca21 release, and Ca21 influx. evidence suggests that the calcium influxfrom the extra-
The results definea molecular circuit by which FcgRIIB cellular space may be selectively inhibited by the
signals block phosphoinositide hydrolysis. FcgRIIB1 signal (Wilson et al., 1987; Choquet et al.,
1993). The antigen receptor signaling cascade appears
Introduction to proceed as follows: ligation of the antigen receptor
leads to rapid tyrosine phosphorylation of BCR trans-
Coligation of the B cell's low-affinity receptor for immu- ducer subunits Iga and Igb (reviewed by Cambier, 1995)
noglobulin G (IgG), FcgRIIB1, with the antigen receptor and BCR-associated CD19 (Chalupny et al., 1993; Tuve-
(BCR), as occurs in vivo when B cells encounter immune son et al., 1993). Phosphorylation of Iga (tyrosines 182
and 193) and Igb (tyrosines 195 and 206) (Flaswinkelcomplexes containing IgG and exposed antigenic epi-
and Reth, 1994; Cambier, 1995) facilitates recruitmenttopes recognized by the BCR, leads to abortive BCR
of Src- and Syk-family kinases that bind BCR phospho-signaling blocking biologic responses to antigen (Chan
tyrosines via their SH2 domains and are consequentlyand Sinclair, 1971; Phillips and Parker, 1983). FcgRIIB1
activated (Clark et al., 1992, 1994; Johnson et al., 1995;knockout mice exhibit enhanced antibody production,
Rowley et al., 1995; Shiue et al., 1995). Phosphorylationparticularly late in the immune response (Takai et al.,
of Syk mediates its association with phospholipase Cg1996). Therefore, FcgRIIB1 appears to play an important
(PLCg), presumably positioning PLCg for activation bynegative regulatory function in the humoral immune re-
Syk (Sillman and Monroe, 1995). BCR-associated Src-sponse.
family kinases bind phosphatidylinositol 3-kinase (PI3K)FcgRIIB1 signaling function is mediated by a 13±
via an SH3 domain±p85 proline-rich region interaction.amino acid cytoplasmic sequence containing a tyrosine
CD19 phosphorylation at tyrosine residues 484 and/orresidue that is phosphorylated upon receptor coligation
515 initiates recruitment and activation of PI3K and per-(Amigorena et al., 1992; Fridman et al., 1992; Muta et
haps Vav (Tuveson et al., 1993; Weng et al., 1994). Based
on this information, we originally hypothesized that
²These authors contributed equally to the study. FcgRIIB1-coupled phosphatases may terminate BCR-
³Present address: Departments of Medicine and Rheumatology, mediated inositol-1,4,5-trisphophate (IP3) generationUniversity of Minnesota, Minneapolis, Minnesota 55455.
and calcium mobilization by dephosphorylating Iga/Igb,§Present address: Roche Milano Ricerche, Department of Biology
Src- or Syk- family tyrosine kinases, or PLCg.and Technology, Hospital S. Raffaele, Via Olgettina 58, Milano, Italy.
Here we describe analysis of thesite in theBCR signal-‖ Present address: Hoechst AG, Molecular Biology, H528, Rhein-
gaustrasse 190, D-65174 Wiesbaden, Germany. ing cascade that is disrupted by FcgRIIB1 signaling,
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Figure 1. Effect of FcgRIIB1 Coligation on
BCR-Mediated Tyrosine Phosphorylation
A20 and IIA1.6 (a FcgRIIB1 negative variant of
A20) B lymphoma cells were cultured without
stimulus (-) or were stimulated with intact (I)
or F(ab9)2 (F) fragments of rabbit antibody to
mouse immunoglobulin (BCR).
(A) Anti-phosphotyrosine immunoblots of
A20 and IIA1.6 lysates (1 3 106 cell equiva-
lents) of cellscultured with and without stimu-
lation for 2 min.
(B) Anti-phosphotyrosine immunoblots of
CD19, Vav, and Iga immunoprecipitates from
A20 and IIA1.6 cells (20 3 106), stimulated for
various time periods (0±300 sec).
(C) Representation of the tyrosine phosphor-
ylation of CD19, Iga, Igb, PLCg2, Lyn, Syk,
and Vav isolated from A20 and IIA1.6 cell ly-
sates normalized to the amount of effector
present in the sample determined by immu-
noblotting. Data are representative of three
independent experiments.
defining an in vivo substrate of operative effectors, cell line A20 and its FcgRIIB1-negative variant IIA1.6
were stimulated with equivalent concentrations of eitherpresumably phosphotyrosine phosphatases, and de-
termining the consequences of reduced substrate phos- intact rabbit anti-mouse immunoglobulin to co-crosslink
BCR and Fc receptor or with F(ab9)2 of the same antibodyphorylation. Results demonstrate that among major
substrates phosphorylated upon BCR ligation, only tocrosslink BCR alone, and the spectraof proteins phos-
phorylated on tyrosine were compared by anti-phos-CD19 exhibits a rapid decrease inphosphorylation when
FcgRIIB1 is co-crosslinked with BCR. This apparent de- photyrosine immunoblotting of whole-cell lysates. Ini-
tially, 2 min stimulation was used because the inhibitoryphosphorylation of CD19 occurs between 15 and 45 sec
following costimulation and results in failed recruitment effects of receptor co-crosslinking on calcium mobiliza-
tion is evident at this point (D'Ambrosio et al., 1995). Asof PI3K to CD19. PI3K inhibitors were found to mimic
the effect of FcgRIIB1 coligation on both BCR-mediated shown in Figure 1A, among the most prominent sub-
strates phosphorylated upon stimulation of BCR aloneIP3 production and Ca21 mobilization, consistent with
mediation of Fc receptor function by failed PI3K activa- (F(ab9)2), visualized selectively by brief exposure of im-
munoblots, only one species was not seen upon BCR±tion. Finally, results of comparative analysis of B cells
from CD192/2 mice and normal littermates support the FcgRIIB1 coligation. This species, which has an appar-
ent molecular mass of approximately 115 kDa, migratedcontention that failed function of CD19 mediates, at least
in part, the FcgRIIB1 effect. Specifically, B cells from at a position corresponding to murine CD19. Consistent
with previous studies, phosphorylation of species identi-CD192/2 mice exhibit reduced Ca21 mobilization remi-
niscent of that seen upon BCR±FcgRIIB1 coligation in fiable as FcgRIIB1 (z50 kDa) and the SHIP PI-3,4,5-P3
59-phosphatase (z160 kDa) were seen when FcgRIIB1CD191/1 cells. Finally, CD192/2 B cellswere not sensitive
to FcgRIIB1-mediated inhibition of Ca21 mobilization. and BCR were crosslinked (Chacko et al., 1996; D'Am-
brosio et al., 1996). Longer exposure of these films did
not reveal additional FcgRIIB1-dependent differencesResults
in protein tyrosine phosphorylation. Neither failed phos-
phorylation of CD19 nor phosphorylation of SHIP andDecreased Tyrosine Phosphorylation of CD19
when FcgRIIB1 is Coligated with BCR FcgRIIB1 was seen when FcgRIIB1-negative cells were
stimulated with intact anti-receptor antibody. TheseTo define the target(s) of FcgRIIB1 effectors in the anti-
gen receptor signaling pathway, we compared the phos- data indicate that among substrates that are most
strongly tyrosine phosphorylated upon BCR ligation,phorylation of major cellular substrates following cross-
linking of BCR alone and co-crosslinking of FcgRIIB1 CD19 may be a substrate for FcgRIIB1-coupled phos-
phatases.with BCR. The FcgRIIB1-positive murine B lymphoma
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(Figure 1 continued from previous page)
To examine directly the effect of FcgRIIB1 coligation anti-effector signal determined. Figure 1C shows the
anti-phosphotyrosine signal normalized for the amounton phosphorylation of proximal mediators of BCR sig-
naling, candidate substrates were immunoprecipitated, of effector present in each lane. Surprisingly, among
substrates analyzed, CD19 was phosphorylated mostfractionated by SDS±polyacrylamide gel electrophore-
sis (SDS-PAGE), and analyzed by sequential immu- rapidly upon BCR ligation. However, CD19 exhibited
significantly reduced levels of tyrosine phosphorylationnoblotting with anti-phosphotyrosine and anti-effector
antibodies. In Figure 1B are shown anti-phosphotyro- when FcgRIIB1 was coligated with the BCR (.80%),
even at the earliest time point tested (15 sec). Con-sine immunoblots of anti-CD19, anti-Iga, and anti-Vav
immunoprecipitates. Blotting with anti-CD19 antibodies versely, slightly more tyrosine-phosphorylated Iga was
detected 15 sec after coligation of FcgRIIB1 and BCRrevealed that equivalent amounts of CD19 were present
in each lane. However, to better demonstrate the effects compared to BCR stimulation alone (Figure 1B). At 45±
120 sec following FcgRIIB1±BCR coligation, reducedof crosslinking BCR alone or co-crosslinking FcgRIIB1
and BCR on the tyrosine phosphorylation state of CD19, phospho-Iga was seen (Figure 1B). However, this re-
flected selective loss of Iga from the detergent-solubleIga, Igb, Vav, PLCg2, Lyn, and Syk, the anti-phosphoty-
rosine and anti-effector blots were scanned and the fraction in these cells as revealed by anti-Iga immu-
noblotting and thuswas not seen when phosphotyrosinepixel density of the anti-phosphotyrosine signal and
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signals were normalized to the amount of Iga present
(Figure 1C). Consistent with their lack of FcgRIIB1 ex-
pression, stimulation of IIA1.6 with either intact or F(ab9)2
anti-receptor antibodies induced equivalent levels and
durations of protein tyrosine phosphorylation of CD19
and Iga (Figures 1B and 1C). Interestingly, stimulation
of IIA1.6 with intact anti-mouse IgG antibody did not
cause a decrease in detergent soluble Iga, indicating
that cytoskeletal association may be FcgRIIB1 depen-
dent. Findings from parallel analysis of Shc, Cbl, and
HS1 phosphorylation (data not shown) revealed no ef-
fect of FcgRIIB1 on these substrates. Finally, IIA1.6 cells
transfected with wild-type FcgRIIB1 behaved equiva-
lently to A20 (D. Fong and J. C. C., unpublished data).
These findings demonstrate that FcgRIIB1 inhibitory sig-
naling involves a selective reduction of CD19 phosphor-
ylation.
The reduced phosphorylation of CD19 seen following
FcgRIIB1±BCR co-crosslinking could reflect either de-
phosphorylation or failure to phosphorylate CD19. How-
ever, kinetic analysis showing greater phosphorylation
of CD19 at 15 sec than at 45 sec following FcgRIIB1±
BCR co-crosslinking (Figures 1B and 1C) supports the
action of a phosphotyrosine phosphatase rather than
failed phosphorylation of CD19.
FcgRIIB1-Mediated Decreases in CD19
Tyrosine Phosphorylation Prevent Figure 2. BCR Ligation±Dependent p85 Association with CD19 Is
its Association with PI3K Prevented by FcgRIIB1 Coligation
Previous studies have shown that phosphorylation of A20 cells (50 3 106 ml/sample) were cultured without stimulus (-) or
were stimulated with intact (I) or F(ab9)2 (F) rabbit antibody to mousetyrosine residue(s) 484 and/or 515 in CD19 leads to bind-
immunoglobulin (BCR) (50 or 32 mg/ml, respectively) for 2 min.ing of PI3K via the SH2 domains of the PI3K p85 subunit
(A) The cells were lysed in 1% NP-40 and CD19 or p85 immunopre-(Tuveson et al., 1993). To investigate whether FcgRIIB1-
cipitated. The immunoprecipitates were washed, eluted with SDS
mediated decreases in CD19 phosphorylation pre- reducing sample buffer, fractionated by SDS-PAGE on a 10% gel,
vented or terminated its association with PI3K, CD19 and transferred to Immobilon-P membranes. The membranes were
and PI3K were immunoprecipitated from Nonidet P-40 sequentially immunoblotted with anti-CD19 and anti-p85.
(B) Coprecipitation of PI3K activity with CD19 was assessed from(NP-40) lysates of intact or F(ab9)2 anti-receptor anti-
A20 cells (10 3 106) that were stimulated and lysed as above. CD19body±stimulated (1 min) A20 cells and coprecipitation
immunoprecipitates were washed and analyzed for PI3K activity asassessed. The immunoprecipitates were fractionated by
described. Data are representative of three experiments.
SDS-PAGE, transferred to polyvinylidene difluoride mem-
brane, and blotted sequentially with anti-CD19 and anti-
PI3K p85. Figure 2A shows, in agreement with previously (Figure 2B). Importantly, coligation of FcgRIIB1 reduced
BCR-induced CD19 association with PI3K activity topublished results (Tuveson et al., 1993), that the amount
of p85 associated with CD19 increases 350% (based on near baseline levels. Consistent with the possibility that
binding of p85 to tyrosine-phosphorylated CD19 resultsdensitometric scanning) when cells are stimulated with
F(ab9)2 anti-BCR antibodies. In contrast, levels of p85 in PI3K activation, the BCR-mediated increase in CD19-
associated PI3K activity (19-fold) could not be ac-associated with CD19 increased by only 60% when cells
were stimulated with intact antibody that co-crosslinked counted for by increases in coprecipitating p85 (3.5-fold),
as determined by immunoblotting. Control experimentsFcgRIIB1 and BCR. This increased association was de-
monstrable by immunoprecipitation with either anti- with the FcgRIIB1-negative cell line IIA1.6 confirmed the
Fc receptor dependence of the decreased associationCD19 or anti-p85. Thus FcgRIIB1 coligation with BCR
caused CD19 dephosphorylation, and this correlated of CD19 and PI3K. Specifically, stimulation of IIA1.6 cells
with intact antibody resulted in a strong induction ofwith reduced association of CD19 with p85.
To assess whether the decreased phosphorylation of CD19 phosphorylation and recruitment of PI3K (Figure
1 and data not shown).CD19 results in decreased recruitment of PI3K activity,
reflecting the p85±p110 complex, to the receptor±
coreceptor complex, PI3K assays were performed on Inhibition of BCR-Mediated Ca21 Mobilization,
but Not CD19 Tyrosine Phosphorylation,CD19 immunoprecipitates from the experiment dis-
cussed above. CD19 isolated from unstimulated cells by PI3K Inhibitors
Previously documented effects of FcgRIIB1 coligationcontained levels of PI3K activity that were only slightly
above the background of the assay. However, following with BCR include premature termination of BCR-medi-
ated IP3 production and calcium mobilization (FigureBCR stimulation (F(ab9)2), the amount of PI3K activity
associated with CD19 was increased more than 19-fold 3) (Bijsterbosch and Klaus, 1985; Wilson et al., 1987;
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Choquet et al., 1993). These findings and those de-
scribed above suggest that abortive IP3 production and
Ca21 mobilization may result from failed PI3K activation.
To determine whether PI3K is involved in BCR activation
of these responses, we assessed the effect of the PI3K
inhibitors wortmannin (Yano et al., 1993; Okada et al.,
1994) and Ly294002 (Vlahos et al., 1994) on BCR-medi-
ated Ca21 mobilization and IP3 production. As shown
in Figure 3, both wortmannin and FcgRIIB1 coligation
inhibited BCR-mediated IP3 production and Ca21 mobili-
zation. When intracellular calcium release and calcium
influx responses were isolated by analyzing the re-
sponses in conditions of low extracellular calcium (cal-
cium buffered to 60 nM using EGTA) followed by calcium
repletion to 1.3 mM, FcgRIIB1 coligation and wortman-
nin were found to affect both responses. Doses of wort-
mannin lower than 1 nM had no effect (data not shown).
These results are consistent with previously reported
half-maximal inhibitory concentration (IC50) values (z3
nM) for inhibition of PI3K in cell-free systems. Also, in
parallel studies, 25 nM wortmannin inhibited PI3K acti-
vation following BCR ligation by approximately 80%
(A. M. B. and J. C. C., unpublished data). BCR-mediated
responses were also sensitive to Ly294002 used at con-
centrations of 10 mM, slightly greater than its IC50 for
PI3K (data not shown).
The data presented in Figure 3 also demonstrate that
the FcgRIIB1 effect is not specific for extracellular cal-
cium influx. This is consistent with the effect of FcgRIIB1
on IP3 production. The more selective effect of FcgRIIB1
co-crosslinking than wortmannin on the late Ca21 mobili-
zation response probably reflects the time required to
activate BCR-coupled kinases, to coaggregate and
phosphorylate FcgRIIB, to recruit and activate FcgRIIB1
effectors, and to dephosphorylate CD19 (Figure 1), be-
fore negative signaling is manifest. To rule out the possi-
bility that wortmannin exerts its effect by blocking CD19
phosphorylation, the phosphorylation of CD19 was as-
sessed in A20 cells that had been pretreated with wort-
mannin (25 nM) and stimulated via BCR crosslinking or
BCR±FcgRIIB1 coligation (Figure 3D). Anti-phosphoty-
rosine immunoblotting of the CD19 immunoprecipitates
revealed no effect of wortmannin on the levels of tyro-Figure 3. Inhibitionof BCR-Mediated IP3 Production and Ca21 Mobi-
lization, but Not CD19 Tyrosine Phosphorylation, by the PI3K Inhibi- sine phosphorylation. These results indicate that PI3K
tor Wortmannin plays an important role in BCR-mediated IP3 production
(A) A20 cells (12 3 106/0.4 ml/sample) were stimulated with F(ab9)2 and Ca21 mobilization and are consistent with the possi-
(12.8 mg) or intact (20 mg) rabbit anti-mouse IgG (RAMIG) in vehicle bility that FcgRIIB1 mediates its effect by preventing
alone (0.2% dimethylsulfoxide [DMSO]) or with F(ab9)2 plus 10 nM PI3K localization in the antigen receptor complex and/
wortmannin in 0.2% DMSO (added 30 min prior to stimulation). At
or activation.the times indicated, cells were harvested and lysed, and cellular IP3
concentrations assayed. The results are shown as fold stimulation
CD19 Expression Is Required for Optimalabove resting levels of 1.41pmol/sample. Results are representative
of four replicate experiments. BCR-Mediated Ca21 Mobilization
(B) A20 cells (1 3 106/ml/sample) were loaded with Indo-1 AM and To address directly whether the function of CD19 and
stimulated with either F(ab9)2 (12.8 mg/ml) or intact (20 mg/ml) rabbit its effectors, such as PI3K, are required for normal Ca21
anti-mouse IgG. Shown is mean [Ca21]i in cells stimulated with intact
mobilization following BCR crosslinking, BCR-mediatedrabbit anti-mouse IgG antibody, F(ab9)2 fragments after preincuba-
Ca21 mobilization was analyzed in dense B cells isolatedtion of cells for 30 min with DMSO (vehicle alone 0.2%), or with 25
nM wortmannin in DMSO. Shown is the mean of the entire population
based on analysis of approximately 900 cells/second.
(C) Equivalent analysis of cells as in (B) above after suspension in
60 nM [Ca21]0 buffered medium followed by repletion of ambient (50 or 32 mg/ml, respectively) for 2 min and lysed and CD19 immuno-
Ca21 to 1.3 mM. precipitated using specific antibodies. The immunoprecipitates
(D) A20 cells (20 3 106/1 ml/sample) were cultured for 30 min with were washed, fractionated by SDS-PAGE, transferred to Immobi-
either DMSO alone (2 wortmannin) or with 25 nM wortmannin in lon-P membranes, and immunoblotted sequentially with anti-phos-
DMSO (1 wortmannin). Cells were left unstimulated (2) or were photyrosine (not shown) and anti-CD19 antibodies.
stimulated with intact (I) or F(ab9)2 (F) rabbit anti-mouse Ig antibody Data are representative of two independent experiments.
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calcium responses have the appearance of FcgRIIB1-
inhibited responses in CD191/1 mice, and FcgRIIB1 coli-
gation does not further suppress this response. Results
indicate that CD19 and, indirectly, its effector PI3K are
targets of FcgRIIB1-coupled phosphotyrosine phospha-
tases, and elimination of CD19 function is probably the
major mechanism of FcgRIIB1 inhibition of phosphoino-
sitide hydrolysis and Ca21 mobilization in normal B cells.
Discussion
In the presence of appropriate complementary signals,
the binding of antigen induces resting B cells to prolifer-
ate and differentiate into antibody-secreting plasma
cells. Chronic expansion of responding B cells has the
potential to cause hyperimmunoglobulinemia and un-
controlled B cell growth. However, negative signaling
pathways allow circulating antigen±IgG antibody com-
plexes to control the numbers of antibody-secreting
cells not only by inhibiting B cell proliferation (Phillips
and Parker, 1983) but also by inducing apoptosis (Ash-
man et al., 1996). This inhibition is accomplished by
immune complex±mediated coligation of the antigen re-
ceptors and the B cell's low-affinity receptors for IgG
(FcgRIIB1).
Recent studies have shown that FcgRIIB1 function is
mediated by phosphorylation of its tyrosine 309 (Muta
et al., 1994). This phosphotyrosine has been shown to
recruit and activate polyphosphatidylinositide and phos-
photyrosine phosphatases, and expression of phospho-
tyrosine phosphatase SHP-1 was found to be required
for FcgRIIB1-mediated inhibition of proliferation (D'Am-
brosio et al., 1995). However, the means by which re-
cruitment and activation of these phosphatases or other
undefined effectors mediate inhibition of BCR signaling
Figure 4. CD19 Expression Is Required for Normal BCR-Mediated was not well understood.
Ca21 Mobilization and for FcgRIIB-Mediated Inhibition of BCR-
Here we have identified a primary substrate forMediated Calcium Mobilization
FcgRIIB1-activated effectors to be CD19, a BCR acces-Dense B cells from CD191/1 and CD192/2 mice were loaded with
sory molecule and coreceptor. During the revision ofIndo-1 AM, and [Ca21]i was analyzed by flow cytometry under the
this manuscript, Kiener et al. (1997) also reported thatfollowing conditions: (A) CD191/1 and CD192/2 (1 3 106 cells/ml)
cells in 1.3 mM [Ca21]0 werestimulated with F(ab9)2 rabbit anti-mouse crosslinking of the Fc receptor and BCR decreases the
IgG (12.8 mg/ml) at the indicated time point (arrow). CD191/1 (B) or tyrosine phosphorylation of CD19. Dephosphorylation
CD192/2 (C) B cells (1 3 106/ml) were stimulated with rabbit anti- of CD19 as indicated by reduced phosphorylation of
mouse IgG antibodies (20 mg/ml) or F(ab9)2 fragments of the same CD19 15±45 sec following stimulation was found to pre-antibody (12.8 mg/ml) at the indicated time point (arrow). Results
vent its recruitment and activation of PI3K. Further ex-are representative of analysis of cells from four individual CD192/2
periments showed that expression of CD19 and functionmice and four individual CD191/1 mice. Shown is the mean [Ca21]i
based on analysis of approximately 900 cells/sec. of PI3K are required for IP3 production and calcium mo-
bilization in response to antigen and for the inhibitory
function of FcgRIIB1 to be manifest. The specific rolefrom the spleens of CD192/2 or wild-type littermates
of PI3K in the CD19 support of these responses is further(Rickert et al., 1995) (Figure 4). Ligation of the BCR in the
demonstrated by studies in a CD19 reconstituted my-CD192/2 B cells resulted in a Ca21 mobilization response
eloma model, where we have shown that mutation ofthat was much reduced compared to that of CD191/1
the PI3K-binding (phospho)tyrosines in CD19 to phenyl-B cells, consistent with requirement for CD19 and its
alanine renders CD19 unable to support BCR-mediatedeffector PI3K for optimal BCR-mediated phosphoinosi-
activation of PI3K, IP3 production, and Ca21 mobilizationtide hydrolysis and Ca21 mobilization. Furthermore,
(A. M. B. et al., unpublished data). In these studies it iswhen FcgRIIB1 function was assessed in CD192/2 cells,
also shown that in cells expressing no CD19 or CD19no FcgRIIB1-mediated inhibition of the residual Ca21
in which tyrosines 484 and 515 are mutated tophenylala-mobilization response was seen (Figure 4C). We also
nine, BCR crosslinking does not lead to detectable PI3Kfound that intact anti-BCR antibodies induce FcgRIIB1
activation. Thus, all BCR-mediated activation of PI3Kphosphorylation in B cells from CD192/2 mice (data not
requires phosphorylation of one or both of these res-shown). These results demonstrate that under condi-
tions in which CD19 does not function, BCR-mediated idues.
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Although the molecular basis of PI3K modulation of The relative role of SHP-1 and SHIP in inhibitory signals
in a particular cell type may depend on a number ofphosphoinoside hydrolysis is unclear, findings that
parameters such as relative expression of the two en-FcgRIIB1 coligation does not inhibit BCR-mediated
zymes and relativeset point inPI-3,4,5-P3 concentration.PLCg phosphorylation (Figure 1C) indicate that a PI3K
Resolution of determinants of the relative roles of theseproduct may somehow be required for hydrolysis of
effectors obviously requires further study.phosphoinositides by phophorylated PLCg. Recent ob-
Recent genetic manipulation of CD19 expression us-servations that the PIP3 polyphosphorylated inositol lipid
ing transgenic and gene-ablated animals has allowedproduct of PI3K binds certain SH2 domains and the
studies that demonstrate a role for CD19 in B cell devel-pleckstrin homology domain of Bruton's tyrosine kinase
opment and immune responses (Zhou et al., 1994; Engel(BTK) raise the possibility that PI3K activation leads to
et al., 1995; Rickert et al., 1995; Sato et al., 1995).Overex-translocation of a critical effector to the plasma mem-
pression of CD19 leads to impaired B cell developmentbrane, where its substrate resides (Rameh et al., 1995;
and reduced B cell numbers in the periphery (Zhou etSalim et al., 1996). Thus, PIP3 may mediate translocation
al., 1994). We hypothesize that overexpression of CD19of, for example, BTK, needed for phosphoinositide hy-
may lead to enhanced BCR±CD19 signaling in responsedrolysis. Interesting in this regard are recent findings
to selecting ligands. This heightened signaling, medi-that BTK expression is required for BCR-mediated cal-
ated by increased PI3K activation, may result in deletioncium mobilization (D. Rawlings, personal communica-
rather than selection of B cells and may be manifest astion). These results are consistent with the possibility
defective B cell development. Studies of the immunethat both aborted IP3 production and aborted calcium
responsiveness of B cells from gene-ablated mice havemobilization consequent to FcgRIIB1 coligation with
revealed that CD19 also plays a critical role in BCR-BCR are mediated by failure to generate PIP3 needed
mediated activation as well as germinal center formationto activate or localize BTK.
and class switching. Thus, CD19 may enhance sensitiv-As noted earlier, phosphorylated FcgRIIB1 has been
ity to antigen by enhancing activation of PI3K and othershown to bind to only three potential effectors in vitro
effectors. Consistent with this hypothesis, co-crosslink-and in vivo (D'Ambrosio et al., 1995; D'Ambrosio et al.,
ing of CD19/CD21 with BCR greatly enhances B cell1996; Ono et al., 1996): SHP-1, SHP-2, and SHIP. Al-
activation (Carter and Fearon, 1992). Based on thesethough either phosphotyrosine phosphatases SHP-1 or
findings, it would be predicted that if CD19 is the target
SHP-2 or downstream effectors of SHIP could mediate
of FcgRIIB1-mediated signaling, the consequences of
the effects described here, it seems most likely given
FcgRIIB1±BCR co-crosslinking in normal B cells should
the findings of D'Ambrosio et al. (1995) that FcgRIIB1
be similar to those of BCR crosslinking in CD192/2 B
is not fully functional in B cells from SHP-1±deficient
cells. This is in fact the case; stimulation in either situa-
(motheaten) mice and that SHP-1 is responsible for the
tion leads to impaired proliferation and antibody produc-
observed effect. Consistent with this possibility, it was tion (Chan and Sinclair, 1971; Engel et al., 1995; Sato et
recently shown that cell-surface expression of SHP-1 al., 1995). Finally, consistent with a role for SHP-1 as a
leads to reduced TCR-mediated IP3 production in Jurkat negative regulator of CD19 signaling are certain pheno-
cells but does not affect PLCg phosphorylation (Musci typic traits of motheaten (SHP-12/2) mice. These mice
et al., 1997). It seems likely, however, that SHIP also exhibit increased levels of circulating immunoglobulin,
plays an important role in FcgRIIB1 signaling. In support as seen in CD191/1 mice relative toCD192/2 mice (Shultz
of this hypothesis are findings that SHIP binds phos- et al., 1993). Lack of SHP-1 in motheaten mice may
phorylated FcgRIIB1 with equal or greater avidity than enhance CD19 signaling, increasing the production of
SHP-1 or SHP-2, and that FcgRIIB1 is capable of trans- circulating immunoglobulin following immunization by
ducing signals inhibitory of FceRI-mediated bone mar- environmental and/or autoantigens.
row mast cell degranulation even in motheaten mice Finally, it is important to realize that FcgRIIB1 may be
(Ono et al., 1996). It should be noted, however, that involved in the inhibition of signaling by other receptors.
FcgRIIB1 inhibition of FceRI-mediated Ca21 mobilization For instance, it has recently been reported that coliga-
in bone marrow mast cells is partially dependent on tion of FcgRIIB1 with the chimeric T cell receptor (TCR)
SHP-1 expression (Fong et al., 1996). We hypothesize inhibits both proliferation and interleukin-2 production,
that SHIP may provide an inhibitory function that is re- and coligation of FcgRIIB1 with FceRI results in inhibition
dundant with SHP-1. Specifically, as a consequence of of serotonin release (Daeron et al., 1995). The concept
FcgRIIB1±BCR coligation, SHIP may dephosphorylate that FcgRIIB1 is involved in inhibiting signaling pathways
PI-3,4,5-P3, forming PI-3,4-P2. SHIP, a 59-inositol phos- in addition to BCR is supported by the finding that mast
phate phosphatase, has been shown to prefer PI-3,4, cells from FcgRIIB1-knockout mice are hypersensitive
5-P3 and I-1,3,4,5-P4 as substrates while being incapable to IgG-triggered degranulation, an FcgRIII-mediated
of hydrolyzing I-1,4,5-P3 (Damen et al., 1996). Thus, while event (Takai et al., 1996). This inhibition occurs even
SHP-1 may act to prevent PI-3,4,5-P3 production, SHIP though mast cells and T cells do not express CD19,
may act to accelerate its degradation. Both enzymes indicating that in these cells a CD19 analog or some
function to reduce PI-3,4,5-P3 that is needed for optimal other mechanism must be operative. A candidate for
PLCg-mediated IP3 production and subsequent calcium the PI3K integrating CD19 analog in T cells is the major
release from internal stores and capacitative calcium TCR-coupled tyrosine kinase substrate pp36/pp38,
entry. Consistent with this possibility are recent data which has been shown to bind PI3K (Fukazawa et al.,
that, when placed in an inert chimeric receptor context 1995). It will be interesting to determine whether the
and crosslinked to BCR, either SHP-1 or SHIP can medi- ability of FcgRIIB1 to inhibit signaling in these cells in-
volves failed activation of PI3K.ate inhibition of calcium mobilization (Ono et al., 1997).
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as previously described (Cambier et al., 1988; Justement et al.,The studies presented elucidate a molecular mecha-
1989). The mean [Ca21]i and percentage of cells that respondednism for integration of positive and negative transmem-
was evaluated with an appended data acquisition system and thebrane signals. The dynamic interplay of these pathways
MultiTIME software (Phoenix Flow Systems). In some cases, intra-
clearly plays an important role in immune regulation but cellular release and extracellular influx components of the calcium
probably have much broader biologic importance. mobilziation response were isolated. To detect only intracellular
calcium release upon stimulation, cells were suspended in medium
in which calcium was buffered to 60 nM (equivalent to [Ca21]i in BExperimental Procedures
cells) using EGTA. They were immediately (within 3 min) stimulated
and [Ca21]i measured. To detect calcium influx, Ca21 in the mediumReagents and Antibodies
Mice from which CD19 was ablated by homologous recombination ([Ca21]0) was repleted to a final concentration of 1.3 mM by addition
were provided by Robert Rickert and Klaus Rajewsky (Cologne, of CaCl2.
Germany) (Rickert et al., 1995). These mice were used at 8±10 weeks
of age as a source of dense splenic B cells (r . 1.066). The murine Analysis of Inositol 1,4,5-Trisphosphate Production
B lymphoma cell lines A20 (FcgRIIB1-positive) (Kim et al., 1979) and Inositol 1,4,5-trisphosphate production was measured using a 3H
IIA1.6 an (FcgRIIB1-negative A20 in variant in which the FcgRIIB radioreceptor binding inhibition assay kit as recommended by the
gene contains a mutation) (Jones et al., 1986) and primary B cells manufacturer (E. I. DuPont).
were cultured in Iscove's modified Dulbecco's medium supple-
mented with 5% heat- inactivated fetal calf serum (Hyclone Inc.),
Acknowledgments50 U/ml penicillin, and 50 mg/ml streptomicin at 378C with 7% CO2.
Antibodies to CD19, Iga, Lyn, Syk, Vav, and PI3K were rabbit poly-
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